Lexitas CEO & Chairwoman, Jeanne Hecht, and CMO, David J. Tanzer, MD, will host a live webinar and Q&A to discuss investment and trial trends, common pitfalls in clinical development, and insights on trial starts for key ophthalmic indications. If you're pursuing investments in the ophthalmic space, be sure to tune in live to ask your questions! #ophthalmology #investment #privateequity
Lexitas Pharma Services
Research Services
Durham, North Carolina 15,055 followers
More than a CRO: Your Partner for Unmatched Expertise and Precision in Ophthalmology Research
About us
Lexitas is a clinical research organization dedicated exclusively to ophthalmology since 2011. With unmatched expertise and precision in ophthalmic research, we deliver tailored approaches, rigorous quality standards, and unwavering commitment to operational success. Our dedicated team of ophthalmic experts guides each study with deep scientific and clinical experience, offering customized solutions to meet your needs at every stage of development. We have extensive experience in posterior and anterior segments, as well as rare diseases. Service Offerings: -Regulatory strategy -Study design and protocol development -Endpoint evaluation and selection -Site selection, management and training -Clinical project management and monitoring -Medical monitoring -Data management & Biostatistics -Reading center -Medical Affairs & commercialization strategies
- Website
-
http://www.lexitas.com/
External link for Lexitas Pharma Services
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- Durham, North Carolina
- Type
- Privately Held
- Founded
- 2011
- Specialties
- CRO, Pharmaceutical Research Services, Ophthalmology, Medical Device Research Services, and Clinical Trial Services
Locations
-
Primary
Get directions
5425 Page Rd
Suite 410
Durham, North Carolina 27703, US
Employees at Lexitas Pharma Services
-
Billy Seawell
Senior Finance Professional | Transforming Business Operations Through Revenue Strategy, Financial Management, and Data-Driven Leadership
-
Joseph Boorady
Serial Entrepreneur I Independent Board Director l Global CEO l Investor l M&A l Medical Devices l Biotech l Private Equity I Business Development
-
Katie (Romans) Thorson
Sr. Director of Clinical Data Management at Lexitas Pharma Services
-
Andy Lipetz
Commercial Operations @ Lexitas
Updates
-
Thank you, Sharron, for featuring our incredible CEO on the #SheLeadsBiotech podcast! If you're in need of some Friday morning listening material, click below ⬇️
CEO |Executive Search | Career Coach | Bioscience | Nonprofit | Host "She Leads Biotech" the podcast. | 40+ year veteran of the recruitment industry
What if the best leaders aren’t the loudest in the room, but the ones who listen, adapt, and show up with honesty? This week on #SheLeadsBiotech, I’m joined by Jeanne Hecht, CEO & Chairwoman of Lexitas Pharma Services, and this conversation is a masterclass in leading with both confidence and humility. We cover: 🔹 The shift from micromanager to mentor, and how she learned to let go 🔹 Why founders need to know when to step aside (and how to do it with grace) 🔹 Building trust with investors, boards, and employees 🔹 Her “CEO of the Year” moment, and what came right before it 🔹 Real talk on leadership, ego, and the power of asking for help “A position of strength is knowing when you’re not in the right role, and making room for someone who is.” This one’s for anyone who’s ever thought they had to have all the answers. Spoiler: you don’t. Full episode now live https://lnkd.in/ewvATxjf #SheLeadsBiotech #JeanneHecht #LexitasPharma #BiotechLeadership #AuthenticLeadership #WomenInSTEM #PrivateEquity #ExecutiveCoaching #LifeSciences #CNAInternationalUSA
-
-
September is #MyopiaActionMonth! This month is all about connecting and empowering eye care professionals, patients, and parents to address childhood myopia. According to the Myopia Action Month website, a 2024 survey revealed that nearly 40% of patients with nearsightedness are still prescribed single-vision lenses. This underscores the importance of educating and supporting individuals who work with or are affected by myopia. Lexitas is proud of the role our experts have played in advancing innovations and empowering practitioners and sponsors who are working to address myopia. To learn more about Myopia Action Month, visit their website today ➡️ https://hubs.li/Q03JRDk80 #MyopiaAction Myopia Profile #MAM2025
-
-
Lexitas Pharma Services reposted this
CEO, NED, Board Member & Chair | Strategist | 2025 TBJ CEO of the Year winner | Dedicated to helping change the way people see the world.
Had a fantastic time discussing innovation, accelerators, and blockers in enhancing patient care at the #HCGO2025 panel. Grateful to the McGuire Woods team for hosting such an engaging conference! #Healthcare #Innovation Lexitas Pharma Services
-
-
Happening this week! Lexitas CEO, Jeanne Hecht, will be in Charlotte this week for the McGuireWoods LLP Healthcare Growth & Operations event. Tomorrow afternoon, Jeanne will join the panel "New Frontiers in Healthcare Investing: Strategic Considerations for Emerging Sectors" alongside other healthcare and investment leaders. Let us know if you're attending!
-
-
Team Lexitas is excited to head to Orlando, Oct 16-20, for Eyecelerator & the American Academy of Ophthalmology Annual Meeting! Members of our Leadership, BD, and Clin Ops teams will join thousands of other ophthalmic experts for a weekend of networking, innovation, and insights. If you're planning to attend either event, you can click below to schedule a time to connect! ⬇️ https://hubs.li/Q03J8y1L0 #AAO2025 #Eyecelerator #ophthalmology
-
-
Lexitas is committed to advancing retinal science, and we're proud to see this reflected in the depth and impact of our work: ➡️ 35+ studies conducted across IRDs, AMD, GA, DME, and retinal detachment, including 10 cell and gene therapy and 17 retinal injection trials ➡️ 468 combined years of retinal expertise across Team Lexitas ➡️ Medical monitors with hands-on experience in all clinical phases, spanning DME, Neovascular AMD, Geographic Atrophy, IRDs, gene and cell therapies, and rare diseases ➡️ Active membership in multiple retinal endpoint consortia and committees—ensuring our voice helps shape the future of retinal research ➡️ In-house reading center offering a device-agnostic platform, real-time access to images, and expertise across every retinal indication ➡️ Lexitas CMO, David J. Tanzer, MD, has contributed to the advancement of novel therapies for chorioretinal vascular disease, macular degeneration, diabetic eye disease, and IRDs. Whether you're looking for development consulting or end-to-end clinical trial support, our retinal experts are here to help. Learn more today: https://hubs.li/Q03HDqBy0 #retina #RP #AMD #Lexitas
-
-
Next week, our CMO, David J. Tanzer, MD, will join his fellow retina experts in Chicago for The Retina Society's 58th Annual Scientific Meeting. This 4-day event is packed with case studies, trends, and innovations in IRDs, AMD, imaging, surgical advancements, and more. Retina expert and Lexitas Board Member, Lejla Vajzovic, MD, FASRS, will share a case study and presentation throughout the week: ➡️ Wed, Sep 10 “A Diagnostic Mystery: Vision Loss in a Hemodialysis Patient" (Case Study) ➡️ Sat, Sep 13 "Intraoperative OCT-Guided Study: Effects of Vitrectomy Technique Modifications and Real-Time Intraocular Pressure Dynamics on Subretinal Bleb Volume" (Presentation) Full agenda in the comments⬇️⬇️ We can't wait to hear David and Lejla's takeaways from this event. Reach out through our website if you're planning to attend and want to catch up! https://hubs.li/Q03GWrgQ0 #retina #ophthalmology
-
Lexitas Pharma Services reposted this
CEO, NED, Board Member & Chair | Strategist | 2025 TBJ CEO of the Year winner | Dedicated to helping change the way people see the world.
Sarah Hines and I are enjoying the EU Ophthalmology Futures Forum! Let’s chat #retina! Lexitas Pharma Services
-